Regional distribution of iron and iron‐regulatory proteins in the brain in aging and Alzheimer's disease
The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
It is well established that iron, which is of considerable importance for normal neurological function, is highly regulated in all organ systems. However, until recently, iron regulation in the nervous system has received little attention. This study quantitatively compares the levels of the major iron‐regulatory proteins, transferrin and ferritin, and iron itself in three cerebral cortical regions of the human brain from material collected at autopsy. Three groups were studied: (1) normal adult (under 65 yr of age), (2) aged (> 65), and (3) Alzheimer's disease. Normally, transferrin is more abundant in white matter than in gray matter. Ferritin is approximately 10 x more abundant than transferrin throughout the brain regions examined and is evenly distributed, as is iron, in the gray and white matter. In Alzheimer's disease transferrin is consistently decreased particularly in the white matter of the various cerebral cortical regions examined whereas the iron and ferritin changes are inconsistent. The observations In this study are consistent with our general hypothesis that iron homeostasis is disrupted in the aging brain and the alterations in iron‐regulatory proteins are exacerbated in Alzheimer's disease. The decrease in transferrin levels could indicate a decreased mobility and subsequent utilization of iron in the brain. Such a decrease in iron availability could play a significant role in neuronal degeneration and increased peroxidative damage known to occur in Alzheimer's disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“ROSs are of course strongly implicated as partial contributors to the aging process (e.g. [31,43,980,1163,1182-1206]).”
Citations
Cites
Bradford, M. M. (1976) · Analytical Biochemistry · doi:10.1016/0003-2697(76)90527-3 · Cited by 255,302
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961
Diagnosis of Alzheimer's Disease
Khachaturian, Z. S. (1985) · Archives of Neurology · doi:10.1001/archneur.1985.04060100083029 · Cited by 2,499
The effect of age on the non-haemin iron in the human brain
Hallgren, B., & Sourander, P. (1958) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1958.tb12607.x · Cited by 1,427 · cited 5×
“, 1990) and iron (Hill and Switzer, 1984; Hallgren and Sourander, 1958) have been reported.”
BackgroundResultInfluentialA white matter disorder in dementia of the Alzheimer type: A pathoanatomical study
Brun, A., & Englund, E. (1986) · Annals of Neurology · doi:10.1002/ana.410190306 · Cited by 1,014 · cited 1×
“Although AD has been considered primarily a neurodegenerative (gray matter) disease, recent studies including those using brain imaging techniques have shown that white matter changes in AD are more common than previously reported (Wallin et al., 1989; Brun and Englund, 1986; Englund et al., 1988; Miller et al., 1980).”
BackgroundThe regional distribution and cellular localization of iron in the rat brain
Hill, J. M., & Switzer, R. C. (1984) · Neuroscience · doi:10.1016/0306-4522(84)90046-0 · Cited by 486
Cellular distribution of transferrin, ferritin, and iron in normal and aged human brains
Connor, J. R., Menzies, S. L., Martin, S. M. S., & Mufson, E. J. (1990) · Journal of Neuroscience Research · doi:10.1002/jnr.490270421 · Cited by 472
Self-citationA histochemical study of iron, transferrin, and ferritin in Alzheimer's diseased brains
Connor, J. R., Menzies, S. L., St. Martin, S. M., & Mufson, E. J. (1992) · Journal of Neuroscience Research · doi:10.1002/jnr.490310111 · Cited by 467
Self-citationMILLER, A. K. H., ALSTON, R. L., & CORSELLIS, J. A. N. (1980) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.1980.tb00283.x · Cited by 347
GOODMAN, L. (1953) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-195308000-00001 · Cited by 286 · cited 3×
“A disruption in brain iron metabolism has been suggested for a number of neurological diseases, including Alzheimer’s disease (Goodman, 1953).”
BackgroundResultInfluential
Cited by
Items 201–300 of 395
Metals and cholesterol: two sides of the same coin in Alzheimer’s disease pathology
Wong, B. X. W., Hung, Y. H., Bush, A. I., & Duce, J. A. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00091 · Cited by 44
“Interestingly, these plaques also have an enrichment of cholesterol (Panchal et al., 2010) and metals such as copper, iron, and zinc (Goodman, 1953; Connor et al., 1992; Bush et al., 1994c; Lovell et al., 1998; Suh et al., 2000; Collingwood et al., 2005; Stoltenberg et al., 2005; Miller et al.,…”
BackgroundIron Deposition in Brain: Does Aging Matter?
Ficiarà, E., Stura, I., & Guiot, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231710018 · Cited by 44
“AD patients had lower transferrin levels in white matter [52].”
BackgroundCeruloplasmin/Transferrin Ratio Changes in Alzheimer′s Disease
Squitti, R., Salustri, C., Siotto, M., Ventriglia, M., Vernieri, F., Lupoi, D., Cassetta, E., & Rossini, P. M. (2010) · International Journal of Alzheimer s Disease · doi:10.4061/2011/231595 · Cited by 44
Metal Chelators Coupled with Nanoparticles as Potential Therapeutic Agents for Alzheimer's Disease
Liu, G., Men, P., Perry, G., & Smith, M. A. (2009) · Journal of Nanoneuroscience · doi:10.1166/jns.2009.005 · Cited by 42
“Evidence also shows that iron metabolism is altered in the brain of AD patients, with alterations including chelatable iron, ferritin and transferrin [68, 69,76,132].”
Background8OHdG levels in brain do not indicate oxidative DNA damage in Alzheimer's disease
Koppele, J. M. T., Lucassen, P. J., Sakkee, A. N., Asten, J. G. V., Ravid, R., Swaab, D. F., & van Bezooijen, C. F. A. (1996) · Neurobiology of Aging · doi:10.1016/s0197-4580(96)00165-0 · Cited by 44
Overweight and Obesity Status Are Linked to Lower Life Expectancy
St‐Onge, M., & Heymsfield, S. B. (2003) · Nutrition Reviews · doi:10.1301/nr.2003.sept.313-316 · Cited by 43
Nishida, H., Kushida, M., Nakajima, Y., Ogawa, Y., Tatewaki, N., Sato, S., & Konishi, T. (2007) · Journal of Pharmacological Sciences · doi:10.1254/jphs.fp0070100 · Cited by 42
Kagerer, S. M., Bergen, J. M. G. V., Li, X., Quevenco, F. C., Gietl, A. F., Studer, S. T., Treyer, V., Meyer, R., Kaufmann, P. A., Nitsch, R. M., et al. (2020) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.12002 · Cited by 41
Lin, Z., Liu, F., Wang, D., & Gu, Y. (2018) · Engineering Analysis with Boundary Elements · doi:10.1016/j.enganabound.2018.10.002 · Cited by 40
Transferrin in the central nervous system of the shiverer mouse myelin mutant
Connor, J. R., Roskams, A. J., Menzies, S. L., & Williams, M. E. (1993) · Journal of Neuroscience Research · doi:10.1002/jnr.490360502 · Cited by 39
Self-citationThe Efficacy and Pharmacological Mechanism of Zn7MT3 to Protect against Alzheimer’s Disease
Xu, W., Xu, Q., Cheng, H., & Tan, X. (2017) · Scientific Reports · doi:10.1038/s41598-017-12800-x · Cited by 39
The Effect of Metals on Spatial Memory in a Transgenic Mouse Model of Alzheimer's Disease
Railey, A. M., Groeber, C. M., & Flinn, J. M. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-101452 · Cited by 39
“Fe is elevated in specific regions of the human AD brain [17, 45], and in the Tg PS/A PP mouse ferritin accumulates in A deposits [5].”
BackgroundDescamps, L., Cecchelli, R., & Torpier, G. (1997) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(96)00226-3 · Cited by 39
Hof, P. R., Bouras, C., & Morrison, J. H. (1999) · Cerebral cortex · doi:10.1007/978-1-4615-4885-0_8 · Cited by 38
Linking multiple pathogenic pathways in Alzheimer’s disease
Khalil, R. B., Khoury, E., & Koussa, S. (2016) · World Journal of Psychiatry · doi:10.5498/wjp.v6.i2.208 · Cited by 38
Effect of Age on MRI Phase Behavior in the Subcortical Deep Gray Matter of Healthy Individuals
Hagemeier, J., Dwyer, M. G., Bergsland, N., Schweser, F., Magnano, C. R., Heininen‐Brown, M., Ramasamy, D. P., Carl, E. M., Kennedy, C. L., Melia, R., et al. (2013) · American Journal of Neuroradiology · doi:10.3174/ajnr.a3569 · Cited by 37
“In addition, findings from the present study largely replicate previous postmortem histopathologic findings.(1,2) SWI-filtered phase imaging is an in vivo method; therefore, all values are merely indirect measurements of iron levels.”
ResultIron and Parkinson's Disease: Chelators to the Rescue?
Levenson, C. W. (2003) · Nutrition Reviews · doi:10.1301/nr.2003.sept.311-313 · Cited by 37
Pathological evidence for oxidative stress in Parkinson's disease and related degenerative disorders
Jenner, P. G., & Olanow, C. W. (1996) · Elsevier eBooks · doi:10.1016/b978-012525445-8/50004-7 · Cited by 37
Kinetics of serotonin oxidation by heme–Aβ relevant to Alzheimer’s disease
Mukherjee, S., Seal, M., & Dey, S. G. (2014) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-014-1193-7 · Cited by 36
Development of ferritin-positive cells in cerebrum of human brain
Ozawa, H., Nishida, A., Mito, T., & Takashima, S. (1994) · Pediatric Neurology · doi:10.1016/0887-8994(94)90066-3 · Cited by 36
Anti-oxidants and cognitive function: a review of clinical and epidemiologic studies
Launer, L. J., & Kalmijn, S. (1998) · Journal of neural transmission. Supplementum · doi:10.1007/978-3-7091-6467-9_1 · Cited by 37
Baringer, S. L., Palsa, K., Spiegelman, V. S., Simpson, I. A., & Connor, J. R. (2023) · Journal of Biomedical Science · doi:10.1186/s12929-023-00934-2 · Cited by 35
“Numerous studies have shown higher regional iron uptake that correspond to areas with higher iron needs [8, 9, 54].”
BackgroundSelf-citationSvobodová, H., Kosnáč, D., Balázsiová, Z., Tanila, H., Miettinen, P. O., Sierra, A., Vitovič, P., Wagner, A., Polák, Š., & Kopáni, M. (2019) · Physiological Research · doi:10.33549/physiolres.934383 · Cited by 34
Maâroufi, K., Save, É., Poucet, B., Sakly, M., Abdelmelek, H., & Had‐Aissouni, L. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.04.003 · Cited by 34
“Iron is also known to accumulate in specific regions of the brain with aging (Connor et al., 1992; Zecca et al., 2004a) and it has been recently shown that iron chelation prevents age-related recognition memory impairment in old rats (de Lima et al.”
BackgroundInfluentialMetal attenuating therapies in neurodegenerative disease
Mot, A. I., Wedd, A. G., Sinclair, L., Brown, D. R., Collins, S. J., & Brazier, M. W. (2011) · Expert Review of Neurotherapeutics · doi:10.1586/ern.11.170 · Cited by 35
Qin, S., Liu, F., Turner, I., Yu, Q., Yang, Q., & Vegh, V. (2016) · Magnetic Resonance in Medicine · doi:10.1002/mrm.26222 · Cited by 33
“Increased concentrations of iron in the human brain have been associated with neurodegenerative diseases and disorders such as Huntington's, Parkinson's and Alzhemier's diseases and multiple sclerosis (1-6).”
BackgroundConnor, D. E., Chaitanya, G. V., Chittiboina, P., McCarthy, P., Scott, L. K., Schrott, L. M., Minagar, A., Nanda, A., & Alexander, J. S. (2017) · Pathophysiology · doi:10.1016/j.pathophys.2017.04.003 · Cited by 33
European Ultrahigh‐Field Imaging Network for Neurodegenerative Diseases (EUFIND)
Düzel, E., Acosta‐Cabronero, J., Berron, D., Biessels, G. J., Björkman‐Burtscher, I. M., Bottlaender, M., Bowtell, R. W., van Buchem, M. A., Cárdenas‐Blanco, A., Boumezbeur, F., et al. (2019) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1016/j.dadm.2019.04.010 · Cited by 32
Oxidative Alterations in Neurodegenerative Diseases
Markesbery, W. R., Montine, T. J., & Lovell, M. A. (2001) · Humana Press eBooks · doi:10.1007/978-1-59259-106-0_2 · Cited by 32
“Transferrin is present around SP in AD (Connor et al., 1992), but transferrin-receptor density is significantly reduced in the hippocampus and neocortex in AD (Kalaria et al., 1992).”
BackgroundNaderi, S., Khodagholi, F., Pourbadie, H. G., Naderi, N., Rafiei, S., Janahmadi, M., Sayehmiri, F., & Motamedi, F. (2022) · NeuroToxicology · doi:10.1016/j.neuro.2022.11.003 · Cited by 31
Yu, W., An, S., Shao, T.-M., Xu, H., Chen, H., Ning, J., Zhou, Y., & Chai, X. (2019) · Aging · doi:10.18632/aging.102522 · Cited by 31
“com 11187 AGING iron contents are observed in the brain of patients suffering from AD [4, 5].”
BackgroundFiciarà, E., Boschi, S., Ansari, S. A., D’Agata, F., Abollino, O., Caroppo, P., Fede, G. D., Indaco, A., Rainero, I., & Guiot, C. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.607858 · Cited by 31
“There are evidences for a variety of interactions between iron and A β : iron accumulates and co-localizes with A β plaques (Connor et al., 1992; Meadowcroft et al., 2009; Ndayisaba et al., 2019), their binding can form redox reactive and toxic species (Nakamura et al., 2007; Bousejra-ElGarah et…”
BackgroundIron Regulation in the Brain at the Cell and Molecular Level
Connor, J. R. (1994) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-2554-7_25 · Cited by 31
Self-citationThe interplay between cell death and senescence in cancer
Shimizu, K., Inuzuka, H., & Tokunaga, F. (2024) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2024.11.001 · Cited by 30
Interaction between iron and omega-3 fatty acids metabolisms: where is the cross-link?
Ogłuszka, M., Lipiński, P., & Starzyński, R. R. (2020) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2020.1862047 · Cited by 30
“Iron-induced tau hyperphosphorylation and its aggregation are considered iron-related etiology of Alzheimer’s disease (Ayton, Lei, and Bush 2013).”
BackgroundInfluentialDüzel, E., Costagli, M., Donatelli, G., Speck, O., & Cosottini, M. (2021) · European Radiology Experimental · doi:10.1186/s41747-021-00221-5 · Cited by 30
Non-invasive assessment of normal and impaired iron homeostasis in the brain
Filo, S., Shaharabani, R., Hanin, D. B., Adam, M., Ben-David, E., Schoffman, H., Margalit, N. S., Habib, N., Shahar, T., & Mezer, A. (2023) · Nature Communications · doi:10.1038/s41467-023-40999-z · Cited by 30
“Importantly, the molecular iron environment varies between cell types and across brain regions 3,5 – 7 .”
InfluentialHe, Y., Lee, T., & Leong, S. K. (1999) · Free Radical Research · doi:10.1080/10715769900301611 · Cited by 30
Brain Samples from Alzheimer's Patients Have Elevated Levels of Loosely Bound Iron
Kala, S. V., Hasinoff, B. B., & Richardson, J. S. (1996) · International Journal of Neuroscience · doi:10.3109/00207459608986717 · Cited by 28
Squitti, R., Reale, G., Tondolo, V., Crescenti, D., Bellini, S., Moci, M., Caliandro, P., Padua, L., & Rongioletti, M. C. A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076867 · Cited by 28
“Then levels of Fe, transferrin, and ferritin were shown to be abnormal in the AD brain [121,122], and Fe was seen to be enriched in neurofibrillary tangles and Aβ plaques made of tau proteins and Aβ peptides, respectively.”
BackgroundRETRACTED: Characterising the spatial and temporal brain metal profile in a mouse model of tauopathy
Rao, S. S., Lago, L., de Vega, R. G., Bray, L., Hare, D. J., Clases, D., Doble, P., & Adlard, P. A. (2019) · Metallomics · doi:10.1039/c9mt00267g · Cited by 28
RetractedHosseinpour-Mashkani, S. M., Bishop, D., Raoufi-Rad, N., Adlard, P. A., Shimoni, O., & Golzan, M. (2023) · Cells · doi:10.3390/cells12081144 · Cited by 27
Metals in Alzheimer’s and Parkinson’s Disease: Relevance to Dementia with Lewy Bodies
McAllum, E. J., & Finkelstein, D. I. (2016) · Journal of Molecular Neuroscience · doi:10.1007/s12031-016-0809-5 · Cited by 27
“As for PD, these changes include increased levels of iron and decreased levels of copper (Connor et al. 1992a; Connor et al. 1992b; Deibel et al. 1996; Graham et al. 2014; Raven et al. 2013).”
BackgroundClaeson, K., Åberg, F. O., & Karlberg, B. (2000) · Journal of Chromatography B Biomedical Sciences and Applications · doi:10.1016/s0378-4347(00)00030-x · Cited by 27
Does human βA4 exert a protective function against oxidative stress in Alzheimer’s disease?
Berthon, G. (2000) · Medical Hypotheses · doi:10.1054/mehy.1999.0924 · Cited by 27
Brain iron metabolism and its perturbation in neurological diseases
Crichton, R. R., Dexter, D. T., & Ward, R. J. (2011) · Monatshefte für Chemie - Chemical Monthly · doi:10.1007/s00706-011-0472-z · Cited by 29
Impacts of Iron Metabolism Dysregulation on Alzheimer’s Disease
Jouini, N., Saied, Z., Sassi, S. B., Nebli, F., Messaoud, T. B., Hentati, F., & Belal, S. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-201250 · Cited by 26
“Giventhat iron dyshomeostasis is pathologically linked to A (cid:2) aggregation [20, 21], which is considered an early biomarker for AD, we hypothesized that iron dysmetabolism would be associated with disturbances in A (cid:2) levels in the CSF.”
Preliminary demonstration of an allelic association of the IREB2 gene with Alzheimer's disease
Coon, K. D., Siegel, A. M., Yee, S. J., Dunckley, T. L., Mueller, C., Nagra, R. M., Tourtellotte, W. W., Reiman, E. M., Papassotiropoulos, A., Petersen, F. F., et al. (2006) · Journal of Alzheimer's Disease · doi:10.3233/jad-2006-9301 · Cited by 22
“Abnormal accumulation of ironin the brainhas beenimpli-cated in a variety of neurodegenerative diseases, most notably AD [9].”
Age modulates the injury-induced metallomic profile in the brain
Portbury, S. D., Hare, D. J., Sgambelloni, C., Bishop, D., Finkelstein, D. I., Doble, P., & Adlard, P. A. (2017) · Metallomics · doi:10.1039/c6mt00260a · Cited by 26
Zhuang, H., Kim, Y., Namiranian, K., & Doré, S. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb07531.x · Cited by 26
Piñero, D. J., Li, N., Hu, J., Connor, J. R., & Beard, J. L. (2001) · Journal of Nutrition · doi:10.1093/jn/131.11.2831 · Cited by 26
Self-citationJózwiak, M., Bauer, M., Kamysz, W., & Kleczkowska, P. (2025) · Pharmaceuticals · doi:10.3390/ph18020185 · Cited by 27
Brain iron metabolism and its perturbation in neurological diseases
Crichton, R. R., Dexter, D. T., & Ward, R. J. (2012) · Springer eBooks · doi:10.1007/978-3-7091-1001-0_1 · Cited by 25
Chemical analysis of the human brain by imaging mass spectrometry
Ajith, A., Sthanikam, Y., & Banerjee, S. (2021) · The Analyst · doi:10.1039/d1an01109j · Cited by 25
Mitophagy and iron: two actors sharing the stage in age-associated neuronal pathologies
Schiavi, A., Strappazzon, F., & Ventura, N. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111252 · Cited by 24
Moreira, P. I., Zhu, X., Lee, H., Honda, K., Smith, M. A., & Perry, G. L. (2006) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2006.01.024 · Cited by 24
“In the brains of patients with AD, iron accumulation occurs without the normal age-related increase in ferritin (Connor et al., 1992), thereby increasing the risk of oxidative stress (Thompson et al.”
BackgroundIron Oxides in the Human Brain
Collingwood, J. F., & Telling, N. D. (2016) · Wiley eBooks · doi:10.1002/9783527691395.ch7 · Cited by 24
Estrés oxidativo, péptido β-amiloide y enfermedad de Alzheimer
Manzano‐León, N., & Mas‐Oliva, J. (2006) · Gaceta Médica de México · Cited by 23
Iron uptake at the blood-brain barrier is influenced by sex and genotype
Wade, Q. W., Chiou, B., & Connor, J. R. (2019) · Advances in pharmacology · doi:10.1016/bs.apha.2019.02.005 · Cited by 23
Self-citationCorrelative Microscopy to Localize and Characterize Iron Deposition in Alzheimer’s Disease
Madsen, S. J., DiGiacomo, P., Zeng, Y., Goubran, M., Chen, Y., Rutt, B. K., Born, D. E., Vogel, H. S., Sinclair, R., & Zeineh, M. (2020) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-200234 · Cited by 23
Investigation of cellular metallic elements in single neurons of human brain tissues
Ishihara, R., Ide‐Ektessabi, A., Ikeda, K., Mizuno, Y., Fujisawa, S., Takeuchi, T., & Ohta, T. (2002) · Neuroreport · doi:10.1097/00001756-200210070-00026 · Cited by 23
Connor, J. R., Malecki, E. A., Cable, E. E., & Isom, H. C. (2002) · Biological Trace Element Research · doi:10.1385/bter:86:1:73 · Cited by 22
“The blood-brain barrier normally guards against excessive iron accumulation in the brain parenchyma (1), and ferritin normally serves as an intracellular defense against the damaging effects of “free” or “labile” iron ( 2 ).”
BackgroundSelf-citationAn unconventional hypothesis of oxidation in alzheimer's disease: intersections with excitotoxicity
Barger, S. W. (2004) · Frontiers in bioscience · doi:10.2741/1481 · Cited by 22
Evaluation of Free Radical-Initiated Oxidant Events within the Nervous System
Bondy, S. C. (1996) · Methods in neurosciences · doi:10.1016/s1043-9471(96)80106-6 · Cited by 22
Perspectives in clinical Alzheimer’s disease research and the development of antidementia drugs
Grundman, M., Corey‐Bloom, J., & Thal, L. J. (1998) · Journal of neural transmission. Supplementum · doi:10.1007/978-3-7091-6467-9_23 · Cited by 22
Fish Models for Exploring Mitochondrial Dysfunction Affecting Neurodegenerative Disorders
Otsuka, T., & Matsui, H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087079 · Cited by 21
Rosenblum, S. L., & Kosman, D. J. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.855751 · Cited by 21
Hironishi, M., Ueyama, E., & Senba, E. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01356-6 · Cited by 20
Modulating Metals As A Therapeutic Strategy For Alzheimer’s Disease
Hung, L. W., & Barnham, K. J. (2012) · Future Medicinal Chemistry · doi:10.4155/fmc.12.32 · Cited by 20
Hall, E. C., Lee, S. Y., Simmons, Z., Neely, E. B., Nandar, W., & Connor, J. R. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.01.004 · Cited by 19
“Furthermore, iron and other metals have been found in euritic plaques and also influence amyloid-beta (Aβ) aggregation [5, 8-10].”
BackgroundSelf-citationValue of transverse relaxometry difference methods for iron in human brain
Uddin, M. N., Lebel, R. M., & Wilman, A. H. (2015) · Magnetic Resonance Imaging · doi:10.1016/j.mri.2015.09.002 · Cited by 19
“For example, optic radiation and internal capsule have high relaxation rates, though they contain low iron [2,47], largely due to densely myelinated fiber pathways [2,48].”
BackgroundDual-pathway multi-echo sequence for simultaneous frequency and T2 mapping
Cheng, C., Mei, C., Duryea, J., Chung, H., Chao, T. C., Panych, L. P., & Madore, B. (2016) · Journal of Magnetic Resonance · doi:10.1016/j.jmr.2016.01.019 · Cited by 19
Role of Metals in Neuronal Apoptosis: Challenges Associated with Neurodegeneration
Ravid, R., & Rao, K. S. J. (2006) · Current Alzheimer Research · doi:10.2174/156720506778249399 · Cited by 19
“An elevation in the amounts of total iron and ferric iron has also been found in frontal cortex and cerebellum from autopsies of brains from AD patients [74].”
BackgroundJunceda, S., Cruz‐Alonso, M., Fernández, B., Pereiro, R., Martínez‐Pinilla, E., & Navarro, A. (2024) · Biomolecules · doi:10.3390/biom14030295 · Cited by 18
“In recent years, an increase in Fe in AD brains has been described, mainly in the cerebral cortex, hippocampus and basal ganglia, but also in other areas, such as the cerebellum or brainstem [7].”
BackgroundInfluentialFinnegan, M. E., Visanji, N. P., Romero‐Canelón, I., House, E. R., Rajan, S., Mosselmans, J. F. W., Hazrati, L., Dobson, J., & Collingwood, J. F. (2019) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2019.03.002 · Cited by 18
“…the AD brain (Samudralwar et al., 1995; Cornett et al., 1998; Loeffler et al., 1995; House et al., 2008; Thompson et al., 1988; Dedman et al., 1992; Connor et al., 1992; Deibel et al., 1996; Tao et al., 2014; Pankhurst et al., 2008; House et al., 2007; Akatsu et al., 2012; Graham et al., 2014;…”
BackgroundEvidence for a Novel Heme-Binding Protein, HasAh, in Alzheimer Disease
Castellani, R. J., Harris, P. L. R., Lecroisey, A., Izadi‐Pruneyre, N., Wandersman, C., Perry, G. L., & Smith, M. A. (2000) · Antioxidants and Redox Signaling · doi:10.1089/ars.2000.2.1-137 · Cited by 18
“However, whereas oxidative damage In A D, there is significant evidence for dis-and antioxidant response are well character-rupted iron homeostasis (Thompson et al, 1988; ized in AD (Smith et al, 1991; Pappolla et al, Connor et al, 1992a,b; Good et al, 1992; Smith 1992; Smith et al, 1994, 1995, 1996a,b), the et al, 19…”
Gromadzka, G., Wilkaniec, A., Tarnacka, B., Hadrian, K., Bendykowska, M., Przybyłkowski, A. M., & Litwin, T. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25147545 · Cited by 17
“These include enhancing the expression of Nrf2, GSH, and catalase to counteract redox stress associated with excessive free iron [152,153].”
BackgroundHosseinpour-Mashkani, S. M., Bishop, D., Westerhausen, M. T., Adlard, P. A., & Golzan, M. (2024) · Metallomics · doi:10.1093/mtomcs/mfae053 · Cited by 18
“The reduction in TF levels may suggest decreased Fe transport and subsequent utilization within the brain [78 ].”
The role of the components of PM2.5 in the incidence of Alzheimer’s disease and related disorders
Zhang, H., Wang, Y., Li, H., Zhu, Q., Ma, T., Liu, Y., & Steenland, K. (2025) · Environment International · doi:10.1016/j.envint.2025.109539 · Cited by 16
“In both WQS and qgcomp models, SO 42,”
Abnormal iron accumulation in the brain of neonatal hypotransferrinemic mice
Takeda, A., Takatsuka, K., Connor, J. R., & Oku, N. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02719-6 · Cited by 16
Self-citationOral curcumin supplementation improves fine motor function in the middle-aged rhesus monkey
Moore, T. L., Bowley, B. G. E., Shultz, P. L., Calderazzo, S. M., Shobin, E., Uprety, A. R., Rosene, D. L., & Moss, M. B. (2018) · Somatosensory & Motor Research · doi:10.1080/08990220.2018.1432481 · Cited by 16
“Inflammation is known to alter iron status and in aging increased inflammation is associated with an increase in ferritin expression (Connor et al. 1992).”
BackgroundInfluence of iron-saturation of plasma transferrin in iron distribution in the brain
Takeda, A., Takatsuka, K., Sotogaku, N., & Oku, N. (2002) · Neurochemistry International · doi:10.1016/s0197-0186(02)00023-2 · Cited by 16
Evidence for Iron Mismanagement in the Brain in Neurological Disorders
Connor, J. R. (1997) · Springer eBooks · doi:10.1007/978-1-4899-0197-2_2 · Cited by 17
Self-citationCellular and regional maintenance of iron homeostasis in the brain: normal and diseased states
Connor, J. R. (1993) · Key topics in brain research · doi:10.1007/978-3-7091-9322-8_1 · Cited by 16
Self-citation[The role of ferroptosis in chronic diseases].
Chen, J., Xiang, Y., Fang, X., Wang, F., & Min, J. (2020) · PubMed Central · doi:10.3785/j.issn.1008-9292.2020.02.24 · Cited by 15
“[65] CONNOR J Rꎬ SNYDER B Sꎬ BEARD J Lꎬ et al.”
Myelin breakdown in Alzheimer’s disease: a commentary
Connor, J. R. (2003) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.06.004 · Cited by 15
Self-citationChemical state imaging of iron in nerve cells from a patient with Parkinsonism-dementia complex
Ide‐Ektessabi, A., Fujisawa, S., & Yoshida, S. (2002) · Journal of Applied Physics · doi:10.1063/1.1426244 · Cited by 15
The synthesis and properties of mitochondrial targeted iron chelators
Cilibrizzi, A., Pourzand, C., Abbate, V., Reelfs, O., Versari, L., Floresta, G., & Hider, R. C. (2022) · BioMetals · doi:10.1007/s10534-022-00383-8 · Cited by 15
DMT1 as a candidate for non‐transferrin‐bound iron uptake in the peripheral nervous system
Vivot, R. M., Goitia, B., Usach, V., & Setton-Avruj, C. P. (2013) · BioFactors · doi:10.1002/biof.1088 · Cited by 14
Serúlópasmín og járn. Tengsl við Alzheimersjúkdóm og Parkinsonsjúkdóm
Jóhannesson, Þ., Kristinsson, J., Þórsdóttir, G., Snædal, J., & Snædal, J. (2012) · Læknablaðið · doi:10.17992/lbl.2012.10.457 · Cited by 14
Butyrylcholinesterase Is Complexed with Transferrin in Chicken Serum
Weitnauer, E., Ebert, C., Hucho, F., Robitzki, A. A., Weise, C., & Layer, P. G. (1999) · Journal of Protein Chemistry · doi:10.1023/a:1020632207361 · Cited by 14
The Role of Oxidative Processes and Metal Ions in Aging and Alzheimer’s Disease
Shinobu, L. A., & Beal, M. F. (1997) · Springer eBooks · doi:10.1007/978-1-4899-0197-2_13 · Cited by 14
Chen, M., Xu, E., Zeng, C., Zhu, W., Zheng, J., & Chen, H. (2021) · Journal of Nutrition · doi:10.1093/jn/nxab189 · Cited by 13
Hayashi, Y., Ueda, Y., Nakajima, A., & Mitsuyama, Y. (2004) · Brain Research · doi:10.1016/j.brainres.2004.07.067 · Cited by 13
Sabbir, M. G. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1469751 · Cited by 11
Neurochemical Aspects of Alzheimer Disease
Farooqui, A. A. (2016) · Springer eBooks · doi:10.1007/978-3-319-15889-1_1 · Cited by 11
Regulation of the ferritin H subunit by vitamin B12 (cobalamin) in rat spinal cord
Cairo, G., Ronchi, R., Buccellato, F. R., Veber, D., Santambrogio, P., & Scalabrino, G. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10267 · Cited by 11
“…evidence of iron accumulation in the brain of patients with neurodegenerative diseases such as Parkinson and Alzheimer disease (Beard et al., 1993; Connor et al., 1992, 1995; Gelman, 1995; Loeffler et al., 1995; Thompson et al., 2001), or demyelinating disease such as multiple sclerosis (Beard et…”
BackgroundZeng, Y., DiGiacomo, P., Madsen, S. J., Zeineh, M., & Sinclair, R. (2021) · Ultramicroscopy · doi:10.1016/j.ultramic.2021.113254 · Cited by 10
David, S., & Patel, B. N. (2000) · Advances in structural biology · doi:10.1016/s1064-6000(00)80010-1 · Cited by 10
Fe2+ decreases the taurine-induced Cl− current in acutely dissociated rat hippocampal neurons
Yu, K., Ge, S., & Ruan, D. (2003) · Brain Research · doi:10.1016/s0006-8993(02)03736-8 · Cited by 10
Metadata
- Authors
- Connor, J. R., Snyder, B. S., Beard, J. L., Fine, R. E., & Mufson, E. J.
- Affiliations
- Pennsylvania State University (US)
- Edith Nourse Rogers Memorial Veterans Hospital (US)
- Corresponding author
- Connor, J. R.
- ORCID
- Snyder, B. S.
- Venue
- Journal of Neuroscience Research
- Publisher
- Wiley
- Published
- 1992-02
- Volume
- 31
- Issue
- 2
- Pages
- 327-335
- ISSN
- 0360-4012 (ISSN-L)
- 1097-4547
- OpenAlex
- W2079887405
- Cited by
- 374
- References
- 46
- Citations by year
- 2026: 3 · 2025: 9 · 2024: 9 · 2023: 13 · 2022: 11 · 2021: 15 · 2020: 14 · 2019: 16 · 2018: 15 · 2017: 12 · 2016: 12 · 2015: 6 · 2014: 11 · 2013: 14 · 2012: 11
- FWCI
- 4.98
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Neuroscience Research (publishedVersion)
- PubMed (publishedVersion)
- Funders
- American Health Assistance Foundation
- National Institutes of Health (5r01ag009063-03)
- National Institute on Aging (AG09063)
- Topics
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
- Health Sciences › Nursing › Nutrition and Dietetics › Trace Elements in Health
- Keywords
- brain iron, iron homeostasis, transferrin, ferritin, Alzheimer's disease, brain aging, cerebral cortex, white matter, gray matter, iron regulatory proteins, neurodegeneration, peroxidative damage
- MeSH terms
- Adult, Aged, Aged, 80 and over, Aging, Alzheimer Disease, Brain Chemistry, Female, Ferritins, Homeostasis, Humans, Iron, Male, Middle Aged, Transferrin, Blotting, Western
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.